2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline | Journal of Clinical Oncology | 2006 | 1.4K |
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer | Journal of Clinical Oncology | 2006 | 1.1K |
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006 | Journal of Clinical Oncology | 2006 | 610 |
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer | Journal of Clinical Oncology | 2006 | 358 |
Radiation therapy for hepatocellular carcinoma: from palliation to cure | Cancer | 2006 | 196 |
Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma | Mayo Clinic Proceedings | 2006 | 193 |
AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy | Blood | 2006 | 114 |
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology | Journal of Clinical Oncology | 2006 | 95 |
Reimbursement for cancer treatment: coverage of off-label drug indications | Journal of Clinical Oncology | 2006 | 63 |
Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas | Journal of Clinical Oncology | 2006 | 63 |
A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008 | Cancer | 2006 | 60 |
Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial | British Journal of Cancer | 2006 | 50 |
ASCO-ESMO consensus statement on quality cancer care | Annals of Oncology | 2006 | 31 |
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 administered as a weekly 24 h continuous intravenous infusion in patients with advanced solid tumors | Cancer Chemotherapy and Pharmacology | 2006 | 5 |
Introduction: ASCO-ESMO consensus statement on quality cancer care | Annals of Oncology | 2006 | 5 |
Cancer biology and implications for practice | Clinical Journal of Oncology Nursing | 2006 | 4 |
Bcr-Abl Kinase Inhibitors | Topics in Medicinal Chemistry | 2006 | 4 |
Evaluating end of life care: The Quality Oncology Practice Initiative (QOPI) experience | Journal of Clinical Oncology | 2006 | 3 |
Introduction: ASCO-ESMO Consensus Statement on Quality Cancer Care | Journal of Clinical Oncology | 2006 | 1 |
We have a new treatment, but you can't afford it | Journal of the National Comprehensive Cancer Network: JNCCN | 2006 | |